Clover Health appoints Scott J. Leffler as CFO effective August 2022

CLOVER HEALTH INVESTMENTS, CORP. /DE

Scott J. Leffler, former CFO of Sotera Health, named permanent CFO; starts August 2022.
Interim CFO Mark C. Herbers will assist transition after Leffler joins.
Base salary $500,000; target bonus 75%; one-time RSU grant worth $12,000,000 with graded vesting.
Signing bonus of $100,000 with repayment clause for voluntary termination within 12 months.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott J. Leffler

Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Filed: May 25, 2022, 7:59 PM ET

Scott J. Leffler will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective upon the commencement of his employment with the Company in August 2022.

Role change

Mark C. Herbers

Interim Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Successor: Scott J. Leffler
Filed: May 25, 2022, 7:59 PM ET

Mr. Leffler will succeed Mark C. Herbers, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Leffler joins the Company and thereafter will assist in the transition.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott J. Leffler was appointed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Scott J. Leffler will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective upon the commencement of his employment with the Company in August 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Mark C. Herbers changed role as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: succeeded
Role: Interim Chief Financial Officer

Exact text from the filing

Mr. Leffler will succeed Mark C. Herbers, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Leffler joins the Company and thereafter will assist in the transition.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-22-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.